Fluorescence Probes

Fluorescence Probes Market Outlook

The global fluorescence probes market is projected to reach approximately USD 8.5 billion by 2035, growing at a CAGR of around 10.5% during the forecast period from 2025 to 2035. This increase can be attributed to rising investments in biopharmaceutical research and development, coupled with advancements in fluorescence microscopy and imaging techniques. The growing demand for personalized medicine has also spurred innovation in fluorescence probes, with researchers increasingly focused on developing probes that provide real-time insights into cellular processes. Additionally, the expansion of applications across various fields such as drug discovery, oncology, and neuroscience has significantly enhanced market potential. These trends signify a robust future for the fluorescence probes market as it adapts to scientific advancements and increasing healthcare needs.

Growth Factor of the Market

The fluorescence probes market has witnessed significant growth owing to several key factors that are driving its expansion. Firstly, the increasing prevalence of chronic diseases globally has necessitated the need for effective diagnostic and research tools, wherein fluorescence probes play a crucial role in enabling in-depth cellular analysis and imaging. Moreover, the rapid advancements in imaging technologies, particularly fluorescence microscopy, are enhancing the capabilities of researchers to visualize complex biological processes at the molecular level. The growing trend of personalized medicine is also a major growth driver, as it emphasizes the development of targeted therapies and diagnostics—areas where fluorescence probes are indispensable. Additionally, the rise of biotechnology and pharmaceutical industries, fueled by increased R&D spending, creates more opportunities for the adoption of these probes. The increasing awareness regarding the importance of early diagnosis and monitoring of diseases is further propelling the market forward.

Key Highlights of the Market

• Significant growth in R&D investments in the biopharmaceutical sector.
• A surge in demand for advanced imaging techniques across various applications.
• Increasing incidence of chronic diseases and the need for early diagnostic tools.
• Advancements in personalized medicine contributing to market growth.
• Rising focus on nanotechnology and its integration with fluorescence probes.

By Product Type

Organic Fluorescent Probes:

Organic fluorescent probes are a dominant segment within the fluorescence probes market due to their widespread application in biological imaging and diagnostics. These probes are characterized by their ability to emit light upon excitation, making them ideal for use in live-cell imaging and various fluorescence-based techniques. The versatility of organic fluorophores, coupled with their tunable properties, allows researchers to modify their chemical structure for specific applications. As a result, organic fluorescent probes are extensively utilized in cell biology, drug discovery, and even environmental monitoring, ensuring their sustained demand in the market.

Inorganic Fluorescent Probes:

Inorganic fluorescent probes, including quantum dots and metal nanoparticles, are gaining traction due to their unique optical properties and stability. These probes often exhibit superior brightness, photostability, and size-tunable emission wavelengths compared to their organic counterparts. As a result, they are increasingly favored in applications like multiplexing, where multiple targets need to be visualized simultaneously. The advancements in synthesis techniques and surface modification are further enhancing their utility, and researchers are now exploring their potential in areas such as biosensing and targeted drug delivery. Consequently, inorganic fluorescent probes are emerging as a significant contributor to the overall market growth.

Fluorescent Proteins:

Fluorescent proteins, such as GFP (Green Fluorescent Protein) and its derivatives, hold a key position in the fluorescence probes market, particularly in cell biology and molecular biology research. These proteins are genetically encoded, allowing for the visualization of live cells in real-time without the need for additional chemical labeling. The ability to tag specific cellular components with fluorescent proteins has revolutionized the study of cellular dynamics and protein interactions. The growing interest in gene editing technologies, including CRISPR, is likely to enhance the adoption of fluorescent proteins, as researchers utilize these tools to study gene expression and function. This segment is expected to witness continued growth as new fluorescent protein variants with improved properties are developed.

Quantum Dots:

Quantum dots are nanoscale semiconductor particles that possess exceptional optical and electronic properties, making them a leading product type in the fluorescence probes market. Their unique characteristics, including size-dependent emission and high photostability, facilitate precise imaging and detection, particularly in complex biological systems. They are employed in applications ranging from in vivo imaging to advanced diagnostics, owing to their ability to emit light across a broad spectrum. The integration of quantum dots with various imaging modalities is enhancing their popularity among researchers, and ongoing advancements in their synthesis and surface functionalization are expected to further boost their market presence.

Nanoparticles:

Nanoparticles represent a versatile category within fluorescence probes, combining the properties of both organic and inorganic probes. They can be engineered for specific functionalities, allowing for targeted imaging and therapeutic applications. Their applicability in drug delivery systems and as contrast agents in imaging technologies enhances their value in the biomedical field. As the demand for multifunctional probes continues to rise, the development of nanoparticles with tailored properties is expanding their adoption across various research and clinical settings. This segment is poised for significant growth, driven by ongoing research and innovations in nanotechnology.

By Application

Cell Biology:

In the realm of cell biology, fluorescence probes are indispensable tools for visualizing and understanding cellular processes. They allow researchers to monitor cellular dynamics, track interactions between proteins, and study intracellular signaling pathways. The ability to label specific organelles and proteins with fluorescent markers has revolutionized the study of cell function and behavior. As research in cell biology continues to expand, the demand for advanced fluorescent probes is expected to grow, positioning this application as a key driver in the fluorescence probes market.

Drug Discovery:

Drug discovery is another critical application area for fluorescence probes, particularly in the screening and profiling of potential therapeutic compounds. These probes facilitate high-throughput screening methods, enabling the identification of lead compounds that interact with specific biological targets. Their role in pharmacokinetic studies, where they can be used to track drug distribution and metabolism in real-time, further enhances their value in drug development. As the pharmaceutical industry increasingly relies on fluorescence-based assays, this segment is anticipated to see substantial growth in the coming years.

Oncology:

Fluorescence probes are rapidly becoming essential in oncology for diagnostics, imaging, and therapeutic applications. Their ability to highlight cancerous cells and tissues enables real-time visualization during surgical procedures, improving the accuracy of tumor resection. Additionally, these probes are utilized in targeted therapies that employ fluorescent markers to deliver drugs directly to cancer cells, minimizing damage to surrounding healthy tissues. The increasing focus on personalized cancer treatments and the need for early detection methods are driving demand for fluorescence probes in oncology, thereby expanding this segment within the market.

Neuroscience:

In neuroscience, fluorescence probes play a crucial role in studying the complex dynamics of neuronal activity and signaling. Researchers use these tools to visualize neural pathways, analyze synaptic interactions, and monitor changes in calcium levels within neurons. The development of specialized probes that can target specific types of neurons has further enhanced their utility in understanding brain function. As neuroscience research continues to advance, particularly in areas of neurodegenerative diseases and mental health disorders, the demand for innovative fluorescence probes is likely to grow significantly.

Immunology:

Immunology is another area where fluorescence probes are making significant contributions, particularly in the study of immune responses and cell interactions. These probes are utilized to visualize immune cell populations, monitor cytokine production, and investigate the mechanisms of immune activation. Their application in flow cytometry and imaging techniques has revolutionized the understanding of immune system dynamics and disease processes. With the ongoing research in vaccine development and autoimmune disorders, the fluorescence probes used in immunology are expected to witness robust growth.

By Distribution Channel

Online Stores:

Online stores have emerged as a significant distribution channel for fluorescence probes, driven by the convenience and accessibility they offer. Researchers and laboratories increasingly prefer online platforms to procure specialized probes due to their extensive product offerings and competitive pricing. Major suppliers make it easier for customers to compare products, read reviews, and access technical information, enhancing the purchasing experience. Additionally, the trend towards e-commerce has accelerated due to the COVID-19 pandemic, resulting in greater reliance on online sales channels for laboratory supplies. As this trend continues, the online distribution channel is anticipated to expand its market share significantly.

Medical Supply Stores:

Medical supply stores remain a vital distribution channel for fluorescence probes, serving healthcare professionals and diagnostic laboratories. These stores provide essential tools and reagents required for various diagnostic applications, including fluorescence microscopy and imaging. The presence of knowledgeable staff and the ability to physically assess products before purchase are notable advantages of this distribution channel. Furthermore, medical supply stores often offer technical support and training for their products, ensuring that customers can utilize the probes effectively in their applications. As healthcare demands continue to rise, medical supply stores are expected to maintain a strong presence in the fluorescence probes market.

Research Laboratories:

Research laboratories are a primary distribution channel for fluorescence probes, as they often require specific and high-quality reagents for their studies. Academic institutions and private research entities frequently conduct experiments that necessitate the use of advanced fluorescence probes, driving demand within this segment. These laboratories often engage in long-term relationships with suppliers to ensure a steady supply of products tailored to their unique research needs. As the global research landscape evolves and expands, the reliance on specialized distributors that cater to research laboratories is expected to increase, bolstering this channel's significance in the market.

Others:

Other distribution channels for fluorescence probes include specialty retailers and distributors that focus on providing a wide range of scientific products and services. These channels may serve niche markets and specific research sectors, catering to unique requirements that larger suppliers may not address. By offering curated selections of products and personalized service, these distributors can effectively compete in the fluorescence probes market. As researchers seek out specialized tools and reagents for their studies, the presence of alternative distribution channels will enhance market accessibility and diversification.

By Fluorophore Type

Fluorescein:

Fluorescein is one of the most widely used fluorophores in the fluorescence probes market, known for its bright green fluorescence and high quantum yield. It is commonly employed in a range of applications, including cell labeling, microscopy, and diagnostic assays. Fluorescein's solubility in water and low toxicity make it ideal for use in live-cell imaging, where the visualization of dynamic processes is critical. Its versatility and stability under various experimental conditions have solidified its position as a cornerstone in fluorescence technology, ensuring its continued prominence in research and development.

Rhodamine:

Rhodamine is another significant fluorophore type that is widely utilized in the fluorescence probes market, particularly for imaging applications. It exhibits strong fluorescence and is characterized by its vibrant pink to red emission, making it suitable for various assays and imaging techniques. Rhodamine-based probes are often employed in applications related to cell biology, environmental monitoring, and chemical sensing. The tunable properties and strong performance of rhodamine derivatives in multiplexing applications have contributed to their popularity among researchers, encouraging further innovations in rhodamine-based probes.

Cyanine:

Cyanine dyes have gained popularity in the fluorescence probes market due to their unique spectral properties and versatility in various applications. These dyes are known for their ability to be engineered for specific wavelengths, catering to a wide array of experimental needs. Cyanine probes are frequently utilized in molecular biology and diagnostics, particularly in applications that require sensitive detection methods and high signal-to-noise ratios. The continuous development of new cyanine derivatives enhances their utility and expands their application scope, ensuring sustained growth for this fluorophore type in the market.

Alexa Fluor:

Alexa Fluor dyes are a premium range of fluorescent dyes known for their exceptional brightness and stability. These dyes have become a popular choice among researchers for their wide spectral range and minimal photobleaching, making them suitable for multicolor imaging applications. The Alexa Fluor family offers a diverse selection of dyes that accommodate various experimental conditions and detection methods, including flow cytometry and immunofluorescence. Their high performance and reliability have established Alexa Fluor dyes as a preferred option for scientists, contributing to their prominent position in the fluorescence probes market.

BODIPY:

BODIPY (Boron-Dipyrromethene) dyes represent a unique class of fluorescent probes that are characterized by their outstanding photophysical properties and chemical stability. These dyes possess remarkable brightness and high molar absorptivity, making them ideal for applications requiring sensitive detection. BODIPY probes are widely employed in biochemistry, cellular imaging, and chemical sensing, showcasing their versatility across various fields. The ongoing development of BODIPY derivatives with enhanced properties further solidifies their role in advancing fluorescence technology and expanding their market share.

By Region

The fluorescence probes market exhibits diverse dynamics across different regions, driven by varying research priorities, healthcare needs, and technological advancements. North America, particularly the United States, leads the market due to significant investments in research and development and a robust biopharmaceutical industry. The region accounted for approximately 40% of the global market share in 2025 and is expected to grow at a CAGR of around 9% through 2035, fueled by advancements in imaging technologies and an increasing number of research institutions. The presence of key players and advanced healthcare facilities further bolsters the market in this region, positioning North America as a critical hub for fluorescence probe innovation.

Europe follows closely as a prominent market for fluorescence probes, driven by extensive research initiatives and a strong focus on healthcare innovation. The region holds about 30% of the global market share, with countries like Germany, the UK, and France leading in research output and biopharmaceutical development. The European market is expected to grow at a CAGR of 8.5% from 2025 to 2035, supported by funding for scientific research projects and collaborative efforts in healthcare. Additionally, the increasing emphasis on precision medicine and advanced diagnostic techniques enhances the demand for fluorescence probes within the region. Asia Pacific is also emerging as a rapidly growing market, with rising investments in biotechnology and pharmaceutical sectors, contributing to a projected CAGR of 11% during the forecast period.

Opportunities

As the fluorescence probes market continues to evolve, several opportunities are emerging that are expected to drive further growth and innovation. One notable opportunity lies in the increasing integration of fluorescence probes with advanced technologies such as artificial intelligence and machine learning. By leveraging these technologies, researchers can gain deeper insights from fluorescence imaging data, enabling more accurate analyses and interpretations in various fields, including drug discovery and cancer research. Additionally, the growing trend of point-of-care diagnostics is creating a demand for rapid and user-friendly fluorescence probes that can be employed outside traditional laboratory settings. This shift is likely to open up new market avenues and encourage the development of innovative probe products tailored to meet the needs of various healthcare environments.

Furthermore, the expansion of applications for fluorescence probes across emerging fields such as synthetic biology and nanotechnology presents significant growth potential. As researchers explore the molecular interactions and functions of biological systems, fluorescence probes will play a critical role in advancing our understanding of complex processes. With the increasing focus on therapeutic development and diagnostics in areas like personalized medicine and gene editing, the need for advanced fluorescence probes tailored to specific applications will continue to rise. This presents substantial opportunities for manufacturers to diversify their product portfolios and collaborate with research institutions to innovate new probe designs that cater to evolving scientific needs.

Threats

Despite the positive outlook for the fluorescence probes market, several threats could hinder its growth trajectory. One major concern is the potential for regulatory challenges associated with the approval and commercialization of new fluorescence probe products. As the market becomes increasingly competitive, stringent regulations regarding safety and efficacy could pose significant barriers for manufacturers seeking to introduce innovative probes. Additionally, the rapid pace of technological advancement may lead to obsolescence for existing products, requiring companies to continuously innovate and adapt to stay relevant. The combined impact of regulatory hurdles and fast-evolving technologies could create uncertainty for market participants, impacting their growth strategies.

Another threat to the fluorescence probes market is the increasing availability of alternative technologies and methodologies that can offer similar imaging and diagnostics capabilities. For instance, advancements in other imaging modalities, such as bioluminescence and mass spectrometry, may divert attention and investment away from fluorescence-based technologies. As researchers explore various approaches to achieve their experimental goals, the relative competitiveness of fluorescence probes could be challenged. Therefore, it is essential for companies in this market to remain vigilant of emerging technologies and continuously communicate the unique advantages of fluorescence probes to sustain their market position.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Life Technologies Corporation (a subsidiary of Thermo Fisher Scientific)
• PerkinElmer, Inc.
• Abcam plc
• Cell Signaling Technology, Inc.
• Syngenta AG
• Promega Corporation
• Enzo Life Sciences, Inc.
• New England Biolabs, Inc.
• Santa Cruz Biotechnology, Inc.
• Fisher Scientific International Inc.
• Jena Bioscience GmbH

The fluorescence probes market is characterized by a diverse and competitive landscape, with numerous established players vying for market share. Leading companies such as Thermo Fisher Scientific Inc. and Merck KGaA have invested significantly in R&D to develop innovative fluorescence probe products and maintain their competitive edge. These companies leverage their extensive product portfolios, global distribution networks, and strong brand recognition to attract customers. Additionally, they often collaborate with academic institutions and research organizations to advance the capabilities of fluorescence probes and address emerging scientific challenges.

Moreover, companies like Bio-Rad Laboratories and GE Healthcare focus on providing high-quality fluorescence imaging solutions that cater to a range of applications, including drug discovery and clinical diagnostics. Their commitment to innovation and customer support enables them to build strong relationships within the scientific community. Furthermore, emerging players such as Jena Bioscience GmbH are entering the market with specialized offerings, targeting niche segments and providing unique solutions to meet specific research needs. This competitive dynamic fosters an environment of continuous improvement and innovation in the fluorescence probes market.

As the market continues to evolve, companies are also exploring strategic acquisitions and partnerships to enhance their capabilities and expand their product offerings. For instance, collaborations between fluorescence probe manufacturers and biotechnology firms enable the development of tailored probes that address specific research applications, fostering innovation. Furthermore, the growing emphasis on personalized medicine and precision diagnostics is driving companies to create specialized fluorescence probes that cater to these emerging trends. Overall, the competitive landscape of the fluorescence probes market is dynamic, with established players and newcomers alike striving to meet the changing demands of researchers and healthcare professionals.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Abcam plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Syngenta AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Promega Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Jena Bioscience GmbH
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Enzo Life Sciences, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 New England Biolabs, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Bio-Rad Laboratories, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Santa Cruz Biotechnology, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cell Signaling Technology, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fisher Scientific International Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Life Technologies Corporation (a subsidiary of Thermo Fisher Scientific)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Fluorescence Probes Market, By Application
    • 6.1.1 Cell Biology
    • 6.1.2 Drug Discovery
    • 6.1.3 Oncology
    • 6.1.4 Neuroscience
    • 6.1.5 Immunology
  • 6.2 Fluorescence Probes Market, By Product Type
    • 6.2.1 Organic Fluorescent Probes
    • 6.2.2 Inorganic Fluorescent Probes
    • 6.2.3 Fluorescent Proteins
    • 6.2.4 Quantum Dots
    • 6.2.5 Nanoparticles
  • 6.3 Fluorescence Probes Market, By Fluorophore Type
    • 6.3.1 Fluorescein
    • 6.3.2 Rhodamine
    • 6.3.3 Cyanine
    • 6.3.4 Alexa Fluor
    • 6.3.5 BODIPY
  • 6.4 Fluorescence Probes Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Medical Supply Stores
    • 6.4.3 Research Laboratories
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Fluorescence Probes Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Fluorescence Probes market is categorized based on

By Product Type

• Organic Fluorescent Probes
• Inorganic Fluorescent Probes
• Fluorescent Proteins
• Quantum Dots
• Nanoparticles

By Application

• Cell Biology
• Drug Discovery
• Oncology
• Neuroscience
• Immunology

By Distribution Channel

• Online Stores
• Medical Supply Stores
• Research Laboratories
• Others

By Fluorophore Type

• Fluorescein
• Rhodamine
• Cyanine
• Alexa Fluor
• BODIPY

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Life Technologies Corporation (a subsidiary of Thermo Fisher Scientific)
• PerkinElmer, Inc.
• Abcam plc
• Cell Signaling Technology, Inc.
• Syngenta AG
• Promega Corporation
• Enzo Life Sciences, Inc.
• New England Biolabs, Inc.
• Santa Cruz Biotechnology, Inc.
• Fisher Scientific International Inc.
• Jena Bioscience GmbH